ScholarWorks@Hanyang University: Yu, Mi Yeon

Detailed Information

Yu, Mi Yeon (유미연)

서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)

Research Area: 내과학

Tel 031-560-2146
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Kidney transplantation:5||Hypertension:3||Proteinuria:3||acute kidney injury:3||Mortality:2||chronic kidney disease:2||clinical research/practice:2||Chronic kidney disease:2||kidney transplantation/nephrology:2||CD44(+) ABCB1(+):1||Cardiovascular:1||Cardiovascular event:1||Cholesterol:1||Chronic Kidney Disease:1||Cohort Studies:1||Covid19:1||Covid19 vaccine:1||Ctr9:1||Death with graft function:1||Dementia:1||Desensitization:1||Diabetes mellitus:1||Dialysis:1||Disparity:1||Dog:1||ESRD risk:1||EndStage Renal Disease:1||Endstage renal disease:1||Frailty:1||Gadoliniumbased Contrast Agents:1||General population:1||Glomerular hypertrophy:1||Glomerulonephritis:1||Glomerulopathy:1||Graft failure:1||HDLC:1||HLAincompatibility:1||Hematuria:1||Hemodialysis:1||Hepatitis A virus:1||Hypertensive crisis:1||IgG AntiHAV:1||Infection:1||KLF15:1||Kidney Failure, Chronic:1||Kidney protection:1||Kidney transplant:1||Koreans:1||Kruppellike factor 15:1||Kruppellike factor 2:1||Malignancy:1||Malnutrition:1||Microscopic polyangiitis:1||Minimal change disease:1||Muscle strength:1||Mutation:1||Nephrectomy:1||Nephrogenic Systemic Fibrosis:1||Nephropathy:1||Neuromuscular electrical stimulation:1||Orofaciodigital syndromes:1||Pericarditis:1||Physical function:1||Podocyte:1||Polycystic kidney diseases:1||Polymicrobial infection:1||Potassium:1||Prognosis:1||Protein supplementation:1||Quality of life:1||Relapse:1||Risk factors:1||Rotational force:1||STAT3:1||Seroprevalence:1||Sex:1||Socioeconomic status:1||Sodium:1||Statins:1||Survival:1||Systemic lupus erythematosus:1||TG:1||Th17 cells:1||Tuberculous lymphadenitis:1||Tuberculous pericarditis:1||Tubuloglomerular feedback:1||Vasculitis:1||angiotensin type1 receptor:1||chemokine ligand 20:1||chemokine receptor 6:1||cyclosporine:1||deceased donor kidneys:1||donor safety:1||emergency department:1||endstage renal disease (ESRD):1||estimated glomerular filtration rate (eGFR):1||glomerular endothelial cell:1||graft outcome:1||graft survival:1||health screening:1||hypertension:1||hypertensive crisis:1||hypoxia:1||infectionmycobacterial:1||infectious disease:1||intracellular tacrolimus:1||ischemiareperfusion injury:1||kidney (allograft) function/dysfunction:1||kidney donor outcomes:1||kidney failure/injury:1||kidney transplantation:1||living kidney donor:1||longterm risk:1||mortality:1||pathology/histopathology:1||podocyte:1||proteinuria:1||rejection:1||renal function:1||safety of donation:1||severity:1||trend:1||다낭성 신장질환:1||단백뇨:1||당뇨병:1||돌연변이:1||사구체병증:1||사구체신염:1||세관 사구체되먹임:1||신이식:1||신장보호:1||알부민뇨:1||입얼굴손발가락증후군:1||ABOincompatibility:1||전신홍반성루프스:1||Albuminuria:1||Allcause mortality:1||AntiNeutrophil Cytoplasmic Antibody (ANCA):1||Antimyeloperoxidase autoantibody:1||Antineutrophil cytoplasmic antibody (anca):1||Asian ethnicity:1||Blood pressure:1||Bronchial fistula:1||

RSS_1.0 RSS_2.0 ATOM_1.0

222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1366

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE